Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Bionomics Limited

Investor presentation - Bionomics Limited

ASX:BNO

Bionomics Limited

Health

Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.

Read more

Market Cap

$110.29m

Price at Close

$0.15

4w avg. Volume

359.40k

4w avg. Turnover

$55.90k

Announcements
announcementt+2 movementdate
  • BNC105 / Nivolumab Treatment Completed in Phase 2 Trial

    Progress Report

  • -3.03%

    19 Jan 2021

-3.03%

19 Jan 2021
  • Publication of Positive BNC210 Phase 2a Data in GAD Patients

    Progress Report

  • +3.45%

    17 Jan 2021

+3.45%

17 Jan 2021
  • BNO Presenting at H.C. Wainwright BioConnect 2021 Conference

    Company Administration

  • 0.00%

    07 Jan 2021

0.00%

07 Jan 2021
  • BNO Initiates 7-Day Dosing Pharmacokinetic Study of BNC210

    Progress Report · Market sensitive

  • 0.00%

    03 Jan 2021

0.00%

03 Jan 2021
  • Lapse of Employee Share Options & Warrants

    Issued Capital

  • +10.71%

    18 Dec 2020

+10.71%

18 Dec 2020
  • Appendix 3Y

    Shareholder Details

  • +8.00%

    24 Nov 2020

+8.00%

24 Nov 2020
  • Final Director's Interest Notice

    Shareholder Details

  • -3.85%

    20 Nov 2020

-3.85%

20 Nov 2020
  • Results of Meeting

    Notice Of Meeting

  • -3.85%

    20 Nov 2020

-3.85%

20 Nov 2020
  • Executive Chairmans 2020 AGM Presentation

    Periodic Reports

  • -3.85%

    19 Nov 2020

-3.85%

19 Nov 2020
  • Bionomics Licenses Drug Candidate BNC101 to Carina Biotech

    Progress Report · Market sensitive

  • +8.33%

    18 Nov 2020

+8.33%

18 Nov 2020
Market Data

Current Price

$0.15

52WK HIGH

$0.19

52WK LOW

$0.03

1YR RETURN

+111.27%

1YR RETURN VS. SECTOR

+71.00%

90 DAY RETURN

+25.00%

ASX RANK

853

/2,048

SECTOR RANK

73

/168

SHARES OUTSTANDING

735.25m
ASX:BNO

Bionomics Limited

Health

Bionomics Limited (BNO) is an Australian biopharmaceutical company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.

Read more

Market Cap

$110.29m

Price at Close

$0.15

4w avg. Volume

359.40k

4w avg. Turnover

$55.90k

ASX:BNO is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.